Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Potassium dihydrogen phosphate has roots stretching back into the 19th century, when chemists first started isolating key mineral salts for use in labs and industrial settings. With growing needs in agriculture and medicine, early investigators found themselves drawn to compounds offering both reliable solubility and purity. Over several decades, researchers honed production and purification practices, especially as requirements from pharmaceutical standards like BP, EP, and USP demanded tighter controls. As analytical equipment improved, companies could keep impurities down, paving the way for today’s pharma-grade material. That continuous march toward higher standards speaks to the value placed on patient safety and reliable therapeutic outcomes in healthcare and related industries.
Potassium dihydrogen phosphate, commonly known by its chemical formula KH2PO4, serves as a white, crystalline salt with a reputation for purity and versatility. In the pharmaceutical arena, it shows up as a buffering agent in injectables, a source of essential potassium, and a key part of various diagnostic preparations. Patients relying on IV fluids, for example, benefit from the controlled electrolyte balance this salt helps achieve. Drug manufacturers often turn to pharma-grade potassium dihydrogen phosphate when recipes require strict oversight of quality and predictability, knowing the stakes involved when formulating medications.
With its monoclinic crystal habit, potassium dihydrogen phosphate draws on strong hydrogen bonding, granting stability across storage conditions. The salt dissolves easily in water, breaking into ions without leaving residues. Heat drives off moisture and can lead to melting around 252°C, a property useful in some analytical settings. Chemically speaking, it behaves as a mild acid in aqueous solutions, donating a single proton and holding pH steady, hence the buffering role. The potent conductivity in solution, coupled with a nearly neutral flavor profile, marks it particularly suitable for clinical scenarios.
Each batch put out for pharmaceutical use lands within a tight window for purity, commonly exceeding 99% assay based on dried substance, as certified by guidelines from BP, EP, and USP collections. Manufacturers flag trace levels of chloride, sulfate, iron, and other metals, guided by pharmacopeia directions that shape labeling. Containers get date stamps, storage advice, and indications for intended applications, all packed into labels that give hospitals or compounding pharmacies confidence. Documentation includes certificates of analysis, tying lot numbers back to test results, anchoring accountability at every step from raw material to finished formulation.
On an industrial scale, potassium dihydrogen phosphate comes from blend-and-react stages starting with purified phosphoric acid and potassium carbonate. Acid gets metered into a reaction vessel with the carbonate, producing gas off as carbon dioxide and leaving the target salt in solution. Controlled cooling then triggers crystallization from the supernatant. Filtration, washing, and drying yield the fine white crystals consumers come to expect. Those making pharmaceuticals depend on water for injections or similarly pure standards in their processes, cutting down the risk of introducing contaminants that might undermine stability or safety in the end product.
In real lab environments, potassium dihydrogen phosphate stands as both reactant and regulator. Mixed with strong bases, its hydrogen gives way to potassium phosphate, morphing acidity and yielding triple or dibasic forms suited to other applications. Heat for extended periods produces pyrophosphate by forcing removal of water, shifting the chemical landscape and opening up supplementary uses in baking or food preservation. Chemists often lean on its buffering power, as it moderates swings in pH during enzyme reactions or biological assays, laying groundwork for reproducibility.
Industry professionals know potassium dihydrogen phosphate under various titles: monopotassium phosphate, MKP, or simply KH2PO4. Some catalogs tag it as E340 for food applications, but in pharmaceutical sheets, the scientific or pharmacopoeial nomenclature stays front and center. In research labs, the shorthand ‘MKP’ has become as recognizable as any trade name, saving space but not clarity, ensuring that even in rushed situations, users know what they reach for.
Anyone handling bulk potassium dihydrogen phosphate must recognize the hazards linked with fine powders and concentrated solutions. While not notorious for acute toxicity, the dust poses risks for eyes and mucous membranes, so gloves, goggles, and dust masks fit into the daily routine. Workers check MSDS information before starting new lots, knowing how oversights in personal protection can set off avoidable workplace incidents. Pharmacopeial compliance also demands strict adherence to GMP protocols, from air filtration in manufacturing areas to process validation and sanitation. By tying operational standards tightly to product specifications, the industry supports not only patient safety but also worker wellbeing.
Hospitals, clinics, and compounding centers keep potassium dihydrogen phosphate in steady rotation, counting on it for intravenous nutrition, acute electrolyte correction, and dialysis solutions. Pharmaceutical researchers apply it in buffers for vaccines, in molecular biology assays, and as stabilizers for proteins prone to denaturing. Choice of this salt often comes from its clean safety record and ability to blend into formulations with a minimum of unwanted side effects. Some labs lean on its phosphate for cell culture—a necessity for healthy cellular metabolism—while food industries, though outside pharma-grade scope, appreciate its leavening and preservative benefits.
In research circles, teams continue probing the boundaries of potassium dihydrogen phosphate. Investigators seek ways to optimize its role in drug delivery systems and to reduce its environmental impact in waste streams. Formulation scientists keep tweaking ratios to control how the salt interacts with biologics, aiming for greater efficacy and fewer side effects. In the biotech field, developers rely on its reliable buffering action for new molecular diagnostics. Each advance in process technology benefits from deeper understanding at the boundaries—what trace impurities do to cell culture, how storage conditions shift after two or three years, what happens at the nano-scale in injectable forms. This ongoing experimentation feeds into updated guidelines, tightening standards and expectations alike.
Toxicologists keep potassium dihydrogen phosphate under surveillance, watching for acute, chronic, and environmental risks. Toxicity in humans only arises in rare cases and mostly where intake grossly exceeds recommended levels. Excessive phosphorus and potassium burden can complicate kidney function in vulnerable populations, but most applications include built-in safety margins. Animal studies and long-term epidemiological data offer confidence, though oversight bodies remain vigilant for any emerging signals. Periodic reviews of the toxicological profile ensure continued safety in line with advances in medical knowledge, offering reassurance to prescribers, patients, and production workers alike.
Signs point toward higher demand for pharma-grade potassium dihydrogen phosphate as the world’s population ages and chronic disease rates rise. Injectable drugs, electrolyte solutions, and biologics pipelines all lean on consistent, pure buffer systems, and this compound sits high on formulators’ lists. New manufacturing technologies—membrane-based purification, continuous crystallization, real-time process analytics—promise to deliver salt at even cleaner specs. Sustainability pressures drive producers to minimize waste, recover spent streams, and trim energy use. As clinical trials uncover fresh uses for potassium and phosphate in combination therapies, the playing field widens. The core lesson rests with careful stewardship and constant improvement so future generations receive medicines of even greater quality, with no corner cut from lab to patient.
At first glance, Potassium Dihydrogen Phosphate looks like chemistry homework material, but its use in the pharmaceutical world actually makes a difference for both drugmakers and patients. In my work with drug developers, this compound stood out again and again because it solves real problems during formulation. It acts as a buffering agent, which sounds simple, but its job is key: Potassium Dihydrogen Phosphate helps keep the pH of liquid medications steady. If the acidity in a drug solution swings too much, the medicine itself can break down or lose effect before patients even get to use it. That goes for vaccines, antibiotics, and even simple saline infusions. The right buffer keeps every dose just as intended, from the factory floor all the way to someone’s bedside.
Not every phosphate salt passes muster with oversight agencies, but the versions that meet BP, EP, and USP grades go through strict checks. In hospital settings, this particular salt often becomes part of intravenous nutrition—patients who can’t eat still need potassium and phosphate, and this is a reliable, controlled way to give both. Too much potassium or phosphate in one’s system spells trouble, so doctors trust pharmaceutical-grade ingredients to avoid dosing mix-ups and side effects. It supports cell energy management, bone health, and nerve function when the body can’t get these elements any other way.
My time spent on a production line brought one thing home: If you want tablets that don’t crumble or stick, the right excipient makes a world of difference. Potassium Dihydrogen Phosphate sometimes works as an excipient—basically a supporting player—so tablets hold their shape and don’t degrade before reaching folks who need them. Some medicines use it to improve how the active ingredient dissolves in water, speeding up the way the medicine gets absorbed once it enters the body. That helps doctors treat patients faster and more effectively.
Pharma grade chemicals get a trial by fire in research labs. Studies looking for new therapies use Potassium Dihydrogen Phosphate to create controlled environments for experiments. Poor quality chemicals skew results, so clean, reliable sources of phosphate are non-negotiable. Clinical trials hinge on consistency. If results aren’t repeatable, decades of work stall; meeting pharmacopeia standards shields against avoidable errors that waste years and drive up costs.
In my experience, pharma-grade Potassium Dihydrogen Phosphate also spotlights a much bigger issue: supply chain transparency. Recalls sometimes happen when raw material suppliers cut corners. For an ingredient like this one, which impacts so many types of medications and nutrition products, any interruption leaves hospitals scrambling. Insisting on traceable, standards-compliant supply lines keeps risks at bay. More attention here will mean fewer batch failures, more predictable costs, and—most importantly—reliable treatment for people who depend on these products.
Pharmaceutical companies take on real responsibility. Potassium Dihydrogen Phosphate, though humble, helps ensure therapies are safe, storage is stable, and production lines keep running. Safe sourcing, regular audits, and open communication between ingredient suppliers and drug companies lay a safer path forward. By prioritizing high-grade inputs and backing every shipment with robust documentation, the industry stands a stronger chance of delivering on its promises to patients and practitioners alike.
Asking for the chemical formula and molecular weight of a product seems like a small thing, but in the world of science and manufacturing, accuracy in these details separates guesswork from real expertise. No one wants to buy a product and realize later they weren't given the information needed to use it safely. Chemical formulas tell us exactly what atoms are in a substance. Molecular weight gives a solid number so you can figure out how much to use. This kind of clarity keeps people safe, avoids accidents, and keeps companies honest.
Chemistry never leaves room for “close enough.” In my own work in labs, mistakes with chemical formulas set off chain reactions leading to ruined experiments or worse, dangerous conditions. You measure wrong, and suddenly your reaction bubbles instead of staying calm. Maybe you’re weighing out sodium chloride and the label only says "salt," without the familiar NaCl or 58.44 g/mol. You take a guess, your ratios go sideways, and your project fails. It takes just one slip to waste a week’s effort.
People trust a product more when they see C8H10N4O2 for caffeine or H2O for water. Those labels become a universal language in research, safety data sheets, and manufacturing logs. In my time training students, explaining the real-world impact of chemical weights turned boring theory into a real-life tool. Say you’re compounding a medicine. You rely on the formula and weight to make sure a patient gets help, not harm. Skipping this step is like baking without measuring cups—disaster is always close.
If someone hands over a product without clear formula or weight, problems pop up fast. In agriculture, spraying a fertilizer with the wrong chemical means wasting a season’s crops. Pharmaceutical teams run trials knowing exactly what chemical sits in every pill. Errors or guesses not only waste money, they risk lives—patients and farmworkers rely on proper handling and labeling. Even in basic cleaning supplies, the difference between harmless soap and a toxic solvent comes down to a few letters and numbers in the formula.
Many governments require chemical labels to show the formula and weight for exactly this reason. This isn’t just tech-speak to fill a form. During chemical spills, emergency workers check the formula to plan their response. Getting rid of doubts makes dangerous work safer. Factories trade chemical ingredients using these numbers, not vague names, because it’s the only way to control quality.
A strong supply chain depends on details. Raw materials passing from one company to the next need to stay labeled straight. If I’m buying a barrel of ethanol, I want C2H5OH, 46.07 g/mol on the paperwork and the drum—without that, what ends up in the batch could spoil it all. Many recalls in industry trace straight back to one skipped label or a missing formula on a bill of lading. Risks pile up fast without transparency.
Manufacturers can solve these problems by always including full formulas and weights on packaging, web listings, and paperwork. Staff should double-check labels before anything ships. Training newcomers in chemical literacy pays off in fewer mistakes and stronger customer trust. Buyers must always ask for this data, not take shortcuts. In short, sharing solid chemical information strengthens every link in the chain from lab bench to loading dock.
Potassium dihydrogen phosphate, with its long science-term name, shows up in many pharmaceutical products for good reason. Folks in the industry recognize this chemical for its purity, reliable supply, and role as a buffering agent. It appears in the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP), meaning big regulators have checked its safety and consistency over time.
Many drug makers rely on it for making injectable solutions or oral medications. It helps control acidity, so that active ingredients don’t break down before doing their job. When putting anything into a product that enters the body, makers can’t cut corners. Every batch needs testing, and only high-purity phosphate makes the grade. Pharmacopeial standards set limits for heavy metals, infectious agents, and impurities, and potassium dihydrogen phosphate passes all of those tests.
Having been involved in lab work, checking excipients for toxicity and irritancy is a routine step before new formulas go near human trials. Reputable studies back up the safety of potassium dihydrogen phosphate at levels found in medication. It is generally well tolerated, but like other phosphates, it shouldn’t go above limits set by doctors or official guidance.
If levels rise too high, it can disrupt electrolyte or phosphate balance in the body, causing trouble—especially for folks with kidney or heart issues. This is no different from other salts used in medicine. A strong regulatory framework keeps an eye out for any changes in reports of side effects. In my work reading through safety data sheets and clinical feedback, adverse reactions show up rarely when handled by trained professionals.
Drug manufacturers follow pharmacopeial rules strictly. That means raw materials like potassium dihydrogen phosphate undergo tests for identity, purity, solubility, and microbial contamination. Instruments measure everything down to a few parts per million. No one wants to mess up an intravenous solution by missing contamination. Audits and batch records get logged for a reason: patient safety.
Global standards from BP, EP, and USP give drug makers confidence to source from vetted suppliers. These rules align well, but some minor differences pop up depending on region. So international companies keep documentation straight and check every delivery. Based on my time observing audits, companies that cut corners or fake certificates get found out eventually, but the process works most of the time.
In recent years, patient interest in drug excipients has jumped. People want to know what’s in their pills and shots. Regulators react to high-profile recalls with more scrutiny. Firms using potassium dihydrogen phosphate must provide data on sources, confirm compliance with up-to-date pharmacopeial editions, and stay alert for ingredient recalls or contamination scares.
Alternatives exist, but few match the blend of safety, function, and availability potassium dihydrogen phosphate offers. Sticking to trusted suppliers, reviewing batch records, and following established safety procedures keeps patient risk low. The chemical has earned its place in pharma through close oversight and hard-won trust from regulators and researchers alike.
Many people working with pharmaceutical ingredients know that proper storage keeps chemicals effective and, more importantly, safe for use in medicines or lab work. Potassium dihydrogen phosphate might just look like another bag of white powder, but it deserves respect in the storage room. Mishandling even a simple salt like this has real consequences—not just spoiling the supply, but risking lab safety or even affecting critical medical products.
Humidity always finds its way in, especially during muggy summers or in rooms without climate control. Potassium dihydrogen phosphate absorbs water fast. Once moisture sneaks in, the powder hardens, clumps, and eventually loses its reliable properties. Trying to break up a solid lump of what should be a free-flowing salt wastes time and money. Keeping it dry goes beyond tossing it in the storeroom and hoping for the best. I’ve seen labs that rely on simple practices: always seal containers right after you take what you need, use airtight drums or bottles, and store them far from sinks or steam sources.
Heat ruins more than just chocolate bars; it breaks down chemicals too. If potassium dihydrogen phosphate sits near radiators or hot pipes, it ages much faster. Its use in medicine means it should remain fresh and reliable, so most manufacturer sheets suggest under 25°C. That matches what most pharmacy stockrooms aim for, using air conditioning and keeping shelving away from sunlit windows.
Sunlight streaming into a storeroom brings more than pleasant rays—it can break down plenty of chemical compounds over time. Potassium dihydrogen phosphate holds up better than some, but pharmaceutical grades get top care. Most facilities choose opaque containers for anything that might react to light, and keep chemicals far from direct light for a little extra insurance. No one wants to find out a batch lost its purity because a window curtain stayed open over a long weekend.
Some people skip labeling, figuring they’ll remember what they put where. I’ve hunted through more than a few storerooms looking for unmarked jars. Pharmacies and labs stick to a rule: every product, including potassium dihydrogen phosphate, gets a clear label showing the grade, the batch, and the expiration date. This habit avoids expensive mix-ups, keeps old stock from getting lost in the back, and stops dangerous mistakes before they happen.
Potassium dihydrogen phosphate reacts easily with strong acids and bases. Keeping incompatible materials apart means less chance of an accidental reaction. In any good lab or stockroom, acids and bases get their own shelves—no exceptions. If someone ignores this, chemical burns or ruined stock soon follow. I’ve seen it happen, and it’s not pretty.
Some of the best storage solutions come not from expensive systems but from daily attention. Make a habit of checking seals and looking over containers for cracks or leaks. Store fresh supplies up front so nothing gets forgotten. Make sure whoever handles storage understands why these routines matter by giving regular safety talks and inspections. Training and organization prevent issues—not just compliance, but because people rely on these products being safe, effective, and available when needed.
Fact: The World Health Organization’s technical report series recommends as little handling as possible, with containers that show tampering—a key step in pharmaceutical storage.Respecting the basics with potassium dihydrogen phosphate may seem routine, but staying disciplined means avoiding big problems down the line.
Walk into any store and you’ll spot all sorts of packaging options for the same item. The sizes on the shelf tell a story about habits, budgets, and even long-term planning. Smaller packs often line the checkout lanes, while larger boxes hug the aisles or fill club store warehouses. Manufacturers pay close attention to who’s buying and how often. This mix isn’t just about giving choice; it’s a way to match real-life needs, keep prices in check, and avoid waste.
Over years of grocery shopping and stocking up for my own family, I’ve noticed some clear patterns. Take cereal, for example. Most brands stick to boxes around 300 to 500 grams for families, but they also put out those single-serve mini packs. These portion-sized boxes help with breakfast-on-the-go without leaving half a box to go stale. Bulk bags, on the other hand, tip the scales at over a kilogram and attract larger households or people who want to save with volume pricing.
Personal care items work the same way. Toothpaste tubes usually come in a 75ml or 100ml size, which fits easily in a drawer and matches a common routine. Bigger family packs land closer to 200ml. There’s a reason for this range — not everyone wants a huge tube or can finish a small one before it dries out, so these choices make sense. Snacks follow a similar path, from lunchbox-ready 25-gram bags to generous multi-packs meant for sharing at gatherings or stocking up for the week.
Laws play a role too. For example, new rules around plastics have pushed companies to rethink how they size and shape containers. In some countries, plastic reduction initiatives have led to more compact, recyclable options. By choosing a size that meets both regulation and customer demand, companies can cut costs and reduce environmental harm. Sometimes, switching to larger packages means using less material overall, which shrinks carbon footprints despite selling more units. Retail giants know this and now highlight bulk or refill-size options as “greener” picks in stores and online.
Size affects what ends up in the trash or the wallet. Small packages almost always cost more per unit, but they keep food fresher and prevent spoilage. Anyone on a tight budget may pick a larger package because of its better value. That can be risky in households that can’t use it all before it’s past its prime. The World Economic Forum reports that food waste problems connect directly to overbuying and oversized packs, especially for perishable goods. The chance to buy the right size matters for cash-strapped families and single households alike.
Brands have started using data to tailor size ranges more closely to how folks shop and live. Flexible options, like resealable bags or variety packs, save time and money while keeping products usable. There’s also a shift toward more conscious packaging, as consumers pay attention to environmental impact. With technology tracking buying patterns and rules getting stricter on waste, more brands have a shot at designing packages that work for both people and the planet. Having these choices doesn’t just fill shelves; it shows respect for buyers from all walks of life.
| Names | |
| Preferred IUPAC name | Potassium dihydrogen phosphate |
| Other names |
Monopotassium Phosphate MKP Potassium Phosphate Monobasic Potassium Dihydrogenorthophosphate KH2PO4 |
| Pronunciation | /pəˈtæsi.əm daɪˈhaɪ.drə.dʒən fəˈsfeɪt/ |
| Identifiers | |
| CAS Number | 7778-77-0 |
| 3D model (JSmol) | `load = "K1H2PO4"` |
| Beilstein Reference | 417383 |
| ChEBI | CHEBI:62947 |
| ChEMBL | CHEMBL1201140 |
| ChemSpider | 70710 |
| DrugBank | DB14526 |
| ECHA InfoCard | ECHA InfoCard: 031-004-00-8 |
| EC Number | 231-913-4 |
| Gmelin Reference | 51638 |
| KEGG | C14389 |
| MeSH | Dihydrogen Phosphate/*pharmacology |
| PubChem CID | 516951 |
| RTECS number | TC6615500 |
| UNII | VZCOHOWNCSCHLLPW |
| UN number | UN1847 |
| Properties | |
| Chemical formula | KH2PO4 |
| Molar mass | 136.09 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 2.338 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -2.0 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 7.2 |
| Basicity (pKb) | 12.4 |
| Magnetic susceptibility (χ) | -1.3e-6 |
| Refractive index (nD) | 1.509 |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 115.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1477 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -2834 kJ/mol |
| Pharmacology | |
| ATC code | A12BA01 |
| Hazards | |
| Main hazards | May cause irritation to eyes, skin, and respiratory system. |
| GHS labelling | GHS07 |
| Pictograms | GHS07, GHS09 |
| Signal word | Warning |
| Hazard statements | No hazard statements. |
| Precautionary statements | P264, P270, P280, P301+P312, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 0-0-0 |
| Lethal dose or concentration | LD50 (oral, rat) 4640 mg/kg |
| LD50 (median dose) | LD50 (median dose): 4640 mg/kg (oral, rat) |
| NIOSH | Not established |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Potassium Dihydrogen Phosphate: Not established |
| REL (Recommended) | not more than 5 mg/kg body weight |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Monopotassium phosphate Dipotassium phosphate Monosodium phosphate Disodium phosphate Phosphoric acid Ammonium dihydrogen phosphate Trisodium phosphate |
Chengguan District, Lanzhou, Gansu, China
